Macro Dragon: Snowflake Powell, +$2T US Taxpayers Flushed Dollars & Exit Afghanistan, HK Equities, US Duration, Gold Macro Dragon: Snowflake Powell, +$2T US Taxpayers Flushed Dollars & Exit Afghanistan, HK Equities, US Duration, Gold Macro Dragon: Snowflake Powell, +$2T US Taxpayers Flushed Dollars & Exit Afghanistan, HK Equities, US Duration, Gold

Macro Dragon: Snowflake Powell, +$2T US Taxpayers Flushed Dollars & Exit Afghanistan, HK Equities, US Duration, Gold

Macro 8 minutes to read

Summary:  Macro Dragon = Cross-Asset Quasi-Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon: Snowflake Powell, +$2T US Taxpayers Flushed Dollars & Exit Afghanistan, HK Equities, US Duration, Gold

Top of Mind…

  • In case you missed the wk ahead piece Macro Dragon WK # 36: Post Jackson Hole, US NFP Fri, Final PMIs Month-End, Afghanistan-End?
  • So its month end as we get into the afternoon session out here in the Asia Pacific – KVP’s concerns around the price action in China Hong Kong Equities continue. I.e. we are still just a string of bad back to back session to retesting the lows, we have not hit escape velocity & a lot of the price action continues to scream “bear market” with harsh brutal rallies, followed by more consistent lower lows…

    Snowflake  HSI
  • With that said, as we get into the end of Aug (caveat there), price action has turned around & we are well of the lows of the morning session. Now likely we are getting some classic month & quarter end window dressing, rebalancing & overall noise that the calendar brings.
  • So the true test will really be how we close for the wk & given that its NFP Fri, could be really a case of next wk (remember US also out on Mon on Labor day wkd
  • We are clearly oversold with some names like JD Health International (6618 HK) & Alibaba Health (241 HK) down c. 50% YTD alone,  whilst the household names like Alibaba(9988 HK, BABA) & Tencent (700 HK) are down anything from -31% to -16%.
  • And yes, KVP’s “favourite” obsession… the lone bull in the China bear market, Weibo (WB $49.01 +0.68%) is still up c. +20% - granted they blew out the water with some stellar quarterly figures (after also a good 1Q) but c’mon man +20% YTD vs. Alibaba -31%, that’s a +50% relative outperformance that is not likely to last  - it has been closing since we flagged this ‘anomaly’, most recent piece was Weibo Erns due pre-mkt Wed, we chk-in with ‘the lone bull’ in a China Tech Bear Mkt. WB $50.76 -3.6% o/n +24 YTD  

    Snowflake  - Relative Tech
  • Lastly just because we are “clearly oversold” does not a floor make. Worth checking out Garnry’s note on China tech below.
  • From KVP’s side he’s looking for price confirmation that takes things above their Aug high, to suggest that we are trying to make a bottom. For instance Tencent 475.20 +2% getting back above $500.

    Snowflake - Tencent
  • The HSI 25,767 +0.89% clearing above 27,000. Alibaba 163.20 +3.2% above 173.

    Snowflake  HSI 2

  • And investors likely need continued regulatory clarity (which we’ve been getting more of), more policy support at some point (Hence KVP like China govies based on the simple yet very high probability thesis that the PBOC is not going to hike), as well as some sectors or even companies being given the good to go.
  • And yes, there is a trillion dollar opportunity to the group of people that can create a regulatory clean & compliant index of China names. At the end of the day, China is 1.4B people, 2nd largest economy on the way to being the first, 2nd largest equity & bond markets on the way to being the first. There is not question that it warrants a place in a long term portfolio – but the timing for going aggressively in, is still suspect.  

 US Afghanistan Exit: Waste +$2T of Taxpayers money over 20yrs, Kudos to Biden for stopping the Mad Circus

Fed’s Dovish Gambit – Will NFP come in at above +1M, or sub 400K on the 750K expectations?

  • Snowflake Powell – KVP was chatting to one of the most experienced & profitable currency traders out there earlier on today (lets call him/her Redemption). So Redemption says (paraphrasing here), Powell is shuffling around like he’s walking on egg shells. And this is just around the damn taper (taking out QE that was put in from a black swan shock, that is no longer in place), it’s not even about a +25bp hike. The guy has the backbone & foundation of a Snowflake. And you know what, Redemption is not wrong.
  • Jun 5th saw an obviously very dovish Powell, forced to acknowledge that inflation was an issue as the Fed shifted slightly to the hawkish side – i.e. he did not wait for jobs data to come in higher, rising inflation in the US forced his hand.
  • This time around, it looks like he is once again banking on the time decay saving him, i.e. signs of inflation reversing. It’s a dangerous gambit – especially if we get NFP numbers coming in at +900K or even +1m & ISMs holding up. We may end up getting a reversal of the risk-on ripple that cascaded from Friday’s Jackson Hole.

Time to be shorting US Duration?... as Gold ignores collapsing Real Yields

  • KVP wants to be short duration all across the US curve… where is the sweet spot?
  • Hmmm… 5s could be getting set-up for the break to 1.5% from these 0.76% lvls for a more tactical move, naturally for a strategic horizon got to be 10s… if they ain’t buying, they are adding to supply baby… & that synthetic pull on QE, should be a synthetic push on QT

    Snowflake 5s
  • Lastly on gold 1816 +0.31%, despite real yields crashing by c. 10bp to -1.84% post JH, the yellow stuff is struggling to break out higher.  

Recent Works to Keep In Heavy Rotation

  • Peter Garnry, Equity Strategy: Is it time to buy Chinese technology stocks?

    “Our Chinese Consumer & Technology basket is the worst performing basket this year due to the ongoing technology crackdown in China. Many investors are asking us whether it is time to buy Chinese technology stocks? The short answer is no. Chinese technology stocks are currently trading at a discount to US technology stocks for good reasons and as long as this discount persists we think investors should focus on Chinese consumer stocks and get exposure to technology in the US. Finally, we take a look at Facebook and Tencent as both companies are pivotal for technology sentiment in the US and China.”
  • KVP weighs in on a potential Asia investor skew into Europe, looking at the UK as a spin-off from the conglomerate & less effective EU. As well as highlighting China Tech’s underperformance in the 1H21,  vs their Global Counterparts especially in ‘Merica.


Start<>End = Gratitude + Integrity + Vision + Tenacity | Process > Outcome | Sizing > Position.

This is The Way


Dragon Interviews:
Dragon Interviews U-Tube Channel for easier play-ability…


The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (
- Full disclaimer (

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo Capital Markets HK Limited holds a Type 1 Regulated Activity (Dealing in securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged foreign exchange trading); Type 4 Regulated Activity (Advising on securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong

By clicking on certain links on this site, you are aware and agree to leave the website of Saxo Capital Markets, proceed on to the linked site managed by Saxo Group and where you will be subject to the terms of that linked site.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

Please note that the information on this site and any product and services we offer are not targeted at investors residing in the United States and Japan, and are not intended for distribution to, or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Please click here to view our full disclaimer.